cagrilintide
Cagrilintide is a synthetic peptide developed for advanced metabolic and appetite-regulation research. It is designed to act as a long-acting analog of amylin, a hormone involved in satiety signaling and energy intake regulation, making it a compound of interest in studies of feeding behavior and metabolic balance.
cagrilintide 5mg
Cagrilintide is a synthetic peptide developed for advanced metabolic and appetite-regulation research. It is designed to act as a long-acting analog of amylin, a hormone involved in satiety signaling and energy intake regulation, making it a compound of interest in studies of feeding behavior and metabolic balance.
Cardiogen 20mg (Bioregulator)
Cardiogen, is a bioregulator peptide which appears to have potent effects on multiple body tissues including the heart and prostate. Additionally, the peptide may be beneficial in the treatment of certain types of cancer, particularly sarcoma. Currently, the biggest benefits of cardiogen appear to be in the settings of heart attack, hypertension, and chronic heart failure where the peptide not only offers benefits of its own accord, but acts in a synergistic manner with established treatments.
Cartalax 20mg (Bioregulator)
Cartalax is a short bioregulatory peptide with widespread systemic impact due to its effects on fibroblasts. It has been shown to benefit skin and other connective tissues as well as the kidneys. Research shows that Cartalax increases cell proliferation rates and beneficially alters the levels of various cytokines and signaling molecules associated with senescence. Overall, it increases cell health and proliferation while decreasing cell death. Cartalax is thought of as an anti-aging peptide, returning older cells to a more youthful state and prolonging overall tissue health.
Chonluten 20mg (Bioregulator)
Chonluten is a short peptide bioregulator of gene expression. Research has shown it to be most active in lung tissue with secondary levels of activity in the GI tract. It regulates genes related to inflammation and antioxidant activity as well as genes involved in proliferation responses to inflammation. Regulation of pulmonary mucosal function by Chonluten may have important applications in chronic inflammatory diseases of the lung such as asthma and COPD.
CJC-1295 without DAC 5ml + IPA 5ml
CJC-1295 (Without DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), developed for research into endocrine signaling and growth hormone regulation. Unlike the DAC-modified version, this form is designed to reflect a shorter activity profile that more closely resembles natural GHRH behavior in biological systems.
CJC-1295 (no DAC), GHRP-2 10mg (Blend)
CJC-1295 (no DAC) and GHRP-2 is a research peptide blend developed to examine synergistic stimulation of the growth hormone axis through dual receptor pathways. CJC-1295 (Mod GRF 1–29) activates the GHRH receptor, initiating cAMP/PKA signaling and GH synthesis, while GHRP-2 binds to the ghrelin receptor (GHS-R1a), triggering Gq/11-mediated calcium influx. This blend is utilized in preclinical studies investigating hypothalamic–pituitary coordination, peptide receptor interaction, and pulsatile hormone release mechanisms.
CJC-1295 (no DAC), Ipamorelin 10mg (Blend)
CJC-1295 5mg (No DAC), Ipamorelin 5mg (10mg Total Peptide Blend)CJC-1295 causes the natural release of GH, but it does so by naturally stimulating the growth hormone releasing hormone receptor. Ipamorelin is one of the most selective growth hormone (GH) secretagogues known and a potent agonist of the ghrelin/growth hormone secretagogue receptor. It has been heavily researched in a number of settings and is known to, improve bone health, boost muscle repair and development, stimulate insulin release from the pancreas, and improve bowel motility and gastric function. CJC-1295 when combined with Ipamorelin has been shown to exhibit synergistic effects when researched together.
CJC-1295 (no DAC), Ipamorelin, GHRP-2 (Blend)
CJC-1295 5mg (No DAC), Ipamorelin 5mg (10mg Total Peptide Blend)CJC-1295 causes the natural release of GH, but it does so by naturally stimulating the growth hormone releasing hormone receptor. Ipamorelin is one of the most selective growth hormone (GH) secretagogues known and a potent agonist of the ghrelin/growth hormone secretagogue receptor. It has been heavily researched in a number of settings and is known to, improve bone health, boost muscle repair and development, stimulate insulin release from the pancreas, and improve bowel motility and gastric function. CJC-1295 when combined with Ipamorelin has been shown to exhibit synergistic effects when researched together.
CJC-1295 no DAC (Mod GRF 1-29)
CJC-1295 5mg (No DAC), Ipamorelin 5mg (10mg Total Peptide Blend)CJC-1295 causes the natural release of GH, but it does so by naturally stimulating the growth hormone releasing hormone receptor. Ipamorelin is one of the most selective growth hormone (GH) secretagogues known and a potent agonist of the ghrelin/growth hormone secretagogue receptor. It has been heavily researched in a number of settings and is known to, improve bone health, boost muscle repair and development, stimulate insulin release from the pancreas, and improve bowel motility and gastric function. CJC-1295 when combined with Ipamorelin has been shown to exhibit synergistic effects when researched together.
